Kidney PATIENT Act of 2024

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [S. 4510 Introduced in Senate (IS)] <DOC> 118th CONGRESS 2d Session S. 4510 To amend the American Taxpayer Relief Act of 2012 to delay implementation of the inclusion of oral-only ESRD-related drugs in the Medicare ESRD prospective payment system. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES June 11, 2024 Mrs. Blackburn (for herself and Mr. Lujan) introduced the following bill; which was read twice and referred to the Committee on Finance _______________________________________________________________________ A BILL To amend the American Taxpayer Relief Act of 2012 to delay implementation of the inclusion of oral-only ESRD-related drugs in the Medicare ESRD prospective payment system. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2024'' or the ``Kidney PATIENT Act of 2024''. SEC. 2. PROHIBITION OF IMPLEMENTATION OF ORAL-ON…